Phathom Pharmaceuticals Inc (PHAT) — Defensive Interval Ratio

Latest as of September 2025: 219 days

Phathom Pharmaceuticals Inc (PHAT) has a Defensive Interval Ratio of 219 days as of September 2025. Defensive assets of $55.79 Million (cash $-, short-term investments $-, receivables $55.79 Million) cover 219 days of daily cash needs of $255.13K/day.

Defensive Interval Ratio

219 days
Days of operational coverage

Defensive Assets

$55.79 Million
Cash + ST Investments + Receivables

Daily Cash Need

$255.13K
Current Liabilities ÷ 365

Current Liabilities

$93.12 Million
USD

Phathom Pharmaceuticals Inc Defensive Interval Ratio (2020–2024)

This chart shows how Phathom Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 219 days, meaning defensive assets of $55.79 Million can fund 219 days of operations without new revenue. For the complete balance sheet picture, see Phathom Pharmaceuticals Inc (PHAT) total assets.

Annual Defensive Interval Ratio for Phathom Pharmaceuticals Inc (2020–2024)

The table below presents the year-by-year Defensive Interval Ratio for Phathom Pharmaceuticals Inc from 2020 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Phathom Pharmaceuticals Inc (PHAT) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 165 days $38.80 Million $234.87K/day $- $- ▲ +150 days
2023 15 days $1.64 Million $106.25K/day $- $- ▲ +15 days
2022 0 days $0.00 $71.88K/day $- $- ▼ -1 days
2020 1 days $82.00K $152.12K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)